Top Markets
#1 Islamic Coin Islamic Coin +151.65%
#2 Black Phoenix Black Phoenix +30.37%
#3 Palladium Network Palladium Network +19.14%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.95%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#6 Fake World Assets Fake World Assets +13.36%
#7 clBTC clBTC +12.17%
#8 Akedo Akedo +11.20%
#9 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.90%
#10 Mantle Staked Ether Mantle Staked Ether +8.50%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals, Inc.

INFI
Classifica tra le azioni #40134
Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge,... Infinity Pharmaceuticals, Inc., established in 1995 and based in Cambridge, Massachusetts, operates as a biopharmaceutical firm dedicated to creating innovative therapies for individuals battling cancer. A central component of its pipeline is IPI-549, an experimental immuno-oncology drug taken orally. This candidate, currently in clinical development, functions by blocking the phosphoinositide-3-kinase-gamma enzyme. IPI-549 is undergoing Phase 2 trials for metastatic triple negative breast cancer and urothelial cancer, and Phase 1/1b trials for various solid tumors. The company maintains several strategic partnerships: with Intellikine, Inc. for the discovery, development, and commercialization of PI3K delta and/or gamma isoform-targeting pharmaceuticals; with Verastem, Inc. for the research, development, commercialization, and production of duvelisib and related compounds; and with PellePharm, Inc. to advance and commercialize its hedgehog inhibitor program, IPI-926, which is also a clinical-stage investigational drug. Furthermore, Infinity Pharmaceuticals holds collaborative agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company.
Prezzo delle azioni
$0.0039
Ultima sincronizzazione: 2023-10-27
Capitalizzazione di mercato
$235.97K
Variazione (1 giorno)
-13.33%
Variazione (1 anno)
0.00%
Paese
US
Scambia Infinity Pharmaceuticals, Inc. (INFI)

Categoria

Healthcare
EPS per Infinity Pharmaceuticals, Inc. (INFI)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Infinity Pharmaceuticals, Inc., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Infinity Pharmaceuticals, Inc. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE